Preventive Healthcare Products Market - COVID 19 Version, 2020 - 2027

Preventive Healthcare Products Market size shall reach a value of $218,876.5 Million in 2020 to 483,866.3 in 2027, growing with a CAGR of 12% during the forecast period of 2020 to 2027.

Preventive Healthcare products are set to witness a high Compounded Annual Growth Rate (CAGR) in the coming years, reason being the increase in chronic and genetic diseases. Preventative health care products are able to decreases the change of non-contagious ailments like diabetes, tumour, cardiovascular diseases etc. The key contributor to the development of global preventive medicine products is rising costs of drugs, high numbers of surgeries, recovery medicines and medical gadgets. The pharmaceuticals companies are taking more interest in preventive healthcare products as they are confronting issues with the customary pharma model, which is neither gainful nor satisfying the demand. Consequently, pharma business has distinguished a sustainable demand in preventive medication, Changing attention to individuals alongside expanding arena of education has positively contributed towards the market growth. The accomplishment of the preventive healthcare products requires an enormous alliance of pharma industry including huge players and new companies with corporate along with educational institutions, which is highly uncommon and can restrain and pose a challenge in the growth of preventive healthcare products market. Another factor constraining development is that counteractive action medication’s capability to confine the healthcare usage has not yet been acknowledged on a vast scale in the light of the fact that the arrival on a venture has never been imparted. North America which is a market leader in almost all segments of health care is lagging behind in preventive healthcare and spares only 0.2% of medicinal services payment notwithstanding when 90% of the population utilizes preventive administrations. European Preventive Healthcare market is growing admirably on account of achievements of the hazard figure the study of disease transmission which has promoted the authorization of a worldwide scope of preventive healthcare measures, for eg; government’s arrangements to confine tobacco publicizing and smoking in open spots, network special occasions for hypertension checking, wellbeing training for weight and various other activities that increase immunity and are preventive in nature in order to avoid grave health consequences. The major players operating in the global preventive healthcare product market include Eli lily, Quanterix, Cancer Prevention Pharmaceuticles, Inc., Novo Nordisk, Astna Inc., American College of Preventive Medicine etc.

Growth and Trends

The worldwide havoc created by the incidence of the Covid-19 pandemic is leading to a surge in growth of the home healthcare market in order to prevent infections and ensure patient safety which are essential objectives in healthcare. The governments have put forward guidelines that are to be followed by caregivers in hospitals and clinics for the prevention of hospital-acquired infections. In recent years, the same guidelines are being followed by home healthcare as well which include the standardization of infection control practices for in-home healthcare, education and training, and the detection of possible contamination between patients and their family members. As a result, the increasing demand to prevent infections and ensure patient safety will drive the growth of the market during the forecast period. Governments of several countries are introducing various programs to improve the accessibility and affordability of healthcare. For instance, certain acts make several physicians reduce costs and improve treatment outcomes through transformation of their practices technologically, clinically, and financially. In consequence, the preference for home-based healthcare and elderly care is showing a rise and the cost of healthcare is lessening, which in turn will exhibit a positive impact on the growth of the preventive healthcare products market. The Covid-19 pandemic will turn out to be beneficial for the nutraceutical industry because people are increasingly consuming preventive healthcare or immunity-boosting supplements, including dietary supplements and vitamins, in order to avoid contracting the viral disease and therefore coping with the present situation, ascertaining thriving market growth.
The challenges associated with the market growth for preventive healthcare products is the disruption in logistics which has been observed to have slowed down the supply chain operations. However, this happens to be a temporary change which will get relaxed once activities around the globe start being resumed at a normal pace.